The new gel is made from natural resin combined with zinc salts which NoBACZ says provides both physical and microbial protection.
NoBACZ says that unlike water-based gels and sprays, including aerosols, that dilute in water and wash away, Ambugreen’s natural resin is hydrophobic which improves contact times between the product and the skin in wet conditions.
The gel barrier can be used anywhere on the skin where a bandage or spray has conventionally been used for protection, such as the management of lameness and to protect sore skin in livestock and to manage udder cleft issues in cows.
Ambugreen also offers fly protection and is suitable for use on all livestock, including copper-sensitive sheep breeds.
Dr David Charles, veterinary surgeon and international business development manager at NoBACZ Healthcare, said: “Ambugreen provides farmers with next generation protection for their livestock and is the perfect antibiotic-free tool to help protect wounds from bacterial ingress from the environment; enhancing the health and welfare of animals whilst preventing economic losses.”
Laura Donovan, veterinary surgeon and partner at Nantwich Farm Vets, adds: “We were lucky enough to have trialled Ambugreen with our dairy clients who have successfully used the gel barrier for udder cleft dermatitis and were very pleased with the results.”
www.nobacz.com
The survey is part of an initiative to develop a 'roadmap' for what needs to happen to support veterinary teams to deliver contextualised care and shared decision-making.
The survey will be used alongside interviews with people in a range of roles in the veterinary sector, including veterinary receptionists and practice managers, to gather insights about what makes it easier or more difficult to practise contextualised care and what could help support its delivery.
Pet owners will also be surveyed and invited to focus groups to understand what matters most to them when making decisions about their pets’ health, and what would help them to feel supported to decide the veterinary care that is right for them and their pet.
Sally Everitt, Clinical Lead – Evidence at RCVS Knowledge, said: “Although the term contextualised care is now being widely used, and a requirement to practise contextualised care is included in the RCVS Guidance for veterinary surgeons and veterinary nurses, there is little information available on how contextualised care is most effectively delivered in practice.
"Our research aims to address a gap in the evidence about what the barriers and enablers are and what needs to change to support veterinary teams to deliver contextualised care.”
The survey is open to veterinary surgeons currently in clinical practice in the UK working with dogs and cats.
The survey can be accessed here until 17th April 2025: https://survey.alchemer.eu/s3/90806393/rcvskresearchprofessionals
Photo: www.depositphotos.com
The company says farmers should be vaccinating their flocks to help protect the cohort of ewes that missed last year’s vaccination.
Flock replacements should also be vaccinated this summer ahead of tupping.
Shearlings (one year plus) and older can be vaccinated with Cevac Chlamydia within four months before tupping and no later than four weeks before the rams go in, while ewe lambs can be vaccinated from five months of age.
The vaccine should not be used in pregnant ewes.
Fiona Lovatt BVSc PhD FHEA DSHP DipECSRHM FRCVS from Flock Health Ltd said: “It is really good news to hear that there will be good availability of EAE vaccine this year.
"The lambing season started off with some disappointing news for some farmers who were not able to vaccinate last year as they faced EAE abortions.
"We are emphasising to these farmers and others that it is essential that the youngest two years of the ewes are vaccinated before next tupping to ensure that the cohort that missed last year’s vaccination are fully covered.”
https://ruminants.ceva.co.uk.
Nutramega contains omega-3 fatty acids, specifically EPA and DHA, which the company says are critical for the overall health of animals, with many health benefits, including joints & mobility, skin & coat, heart health, the kidneys and brain health.
Nutramega comes in two sizes, 100ml and 200ml, with prices starting from £20.00.
Pet Ready LifeStages are health chews designed to provide daily support for puppies, adult dogs and senior dogs.
Each LifeStage product comes in 30 and 90 chew packets and prices range from £19.99 to £34.99.
www.nutravet.co.uk
Led by Navaratnam Partheeban (Theeb) (pictured) OBE, Regional Head of Farm at IVC Evidensia, the programme is based on a methodology developed in the Netherlands.
The training focuses on the main behavioural indicators in cattle, helping vets and farmers assess health and welfare using basic senses such as looking, smelling, and feeling.
The one-day course includes a morning theory session followed by an on-farm practical session, equipping participants with skills to spot early signs of health or welfare issues before they become serious.
Theeb said: "Our goal is to train all our farm vets and vet techs in this approach, so they can provide even greater support to farmers.
"By integrating cow signals into routine practice, we can help farmers improve herd welfare, increase productivity, and contribute to more sustainable farming.
"Healthier cows live longer, produce more milk, and require less medical intervention.”
Petra Grabnar Rogers, Farm Veterinary Surgeon at Delaware Vets, an IVC Farm practice in Somerset, said: "The cow signals training has made a noticeable difference for our farmers.
"Being able to spot early signs of distress or health issues before they become bigger problems will help our farmers reduce vet visits and improve overall herd health.
"It's a simple yet effective approach that we hope will have a positive impact on the productivity of our farm clients."
IVC says that whilst this methodology is known in the UK, opportunities to receive formal training have traditionally been limited and it is the first corporate group to provide widespread cow signals training to all its farm vets.
Tim, who is Managing Partner of Larkmead Vets and also a Director at the independent veterinary community XLVets, graduated from Liverpool Vet School in 1994 and joined Larkmead Vets in 1998.
He said: “I grew up in the South Yorkshire coalfields and worked in a city centre small animal practice in Wakefield before relocating to Oxfordshire to develop the small animal department of a mixed practice.
"First-opinion veterinary practice has been my life since starting cleaning kennels aged 12.
“I am passionate that whilst what we do is work with animals, how we do it is by working with people: our colleagues and the owners who entrust their animals to our care.
"As a first-opinion vet and practice owner I have had the privilege of growing and developing my practice (team and facilities) to meet the changing needs of our local community.
“At a time of great change for the veterinary profession, with the tantalising hope for a new Veterinary Surgeons Act set against the backdrop of the Competition and Markets Authority’s market investigation of the veterinary sector, it is an opportunity to bring this experience to the heart of our College.
“It was an unexpected honour to be elected to the position of JVP and I thank my colleagues on Council for entrusting the role to me.
"I also reflect on my initial university application which saw a clean sweep of rejections and hope that this can inspire others from the grass roots of our profession to get involved in shaping the future.”
Council also voted to confirm Professor Tim Parkin as RCVS President, Linda Belton as Senior Vice-President and reconfirmed Tshidi Gardiner as Treasurer (subject to her re-election), all effective from July.
Tim will take up his post at the College's AGM in July.
The webinar is being presented by Cassie Woods (RVN Cons) CertNCS, Equine Nurse and Partner at Lower House Equine Clinic in Shropshire.
Cassie has a degree in bio-veterinary science and many years experience working in equine and small animal practice.
She regularly lectures for BVNA and BEVA. She is a member of the BEVA equine nurse committee and works closely with the BEVA Trust.
Cassie will share insights and practical strategies to strengthen biosecurity for both clinic and ambulatory teams, and will offer advice and guidance for helping clients to improve their own biosecurity measures.
Horiba's Veterinary specialists will also be available to answer veterinary diagnostics-related questions and share information about the range of pathogen tests the company offers.
https://horiba.link/register-143bbc
The updated indications reflect the recognition that Stelfonta may be used in any case where surgery may not be an option:
For the treatment of non-metastatic (WHO staging) mast cell tumours that are either non-resectable or those that are resectable but where surgery is not considered the best option, specifically: cutaneous mast cell tumours (located anywhere on the dog) and subcutaneous mast cell tumours located at or distal to the elbow or the hock.
Tumours must be less than or equal to 8 cm 3 in volume, and must be accessible to intratumoral injection.
Neil Mottram MRCVS, Technical Manager at Virbac said: “Stelfonta offers veterinary surgeons a medical option for the successful elimination of mast cell tumours.
"The extended labelled indication demonstrates the wide variety of cases that can benefit where medical treatment is preferred, such as; tumour factors (location and size) making surgical margins difficult, patient factors (concurrent disease and risk of anaesthesia), clinic factors and the simplification of this medical treatment and owner factors, where there is a preference to avoid surgery."
Stelfonta is administered by injection directly into the tumour mass and Virbac say that generally, dogs do not require sedation or local or general anaesthesia during treatment.
The active ingredient, Tigilanol tiglate, works largely through specific protein kinase c (PKC) activation, in which it locally stimulates the immune system, resulting in destruction of the tumour and the tumour’s blood supply, followed by rapid healing of the site with minimal scarring.
www.virbac.co.uk
The device emits low dose 265 nanometre (nm) ultraviolet C light at a targeted area.
In a 2022 in vitro / ex vivo study to evaluate the therapeutic potential of 265nm UVC for infectious keratitis1, UVC was found to inhibit all tested bacteria and fungi, including mixed culture and strains linked to antibiotic resistance.
In the study, no evidence of infection was found from 4 hours onwards, ulcers responded significantly in under 24 hours, and at the end point, those treated with UVC performed as as well as those treated with ciprofloxacin.
Photon Therapeutics says that in simple cases, one five-second treatment will suffice, but more complex cases can be re-treated after 24 hours.
Currently, there are two main barriers to the successful treatment of eye infections in dogs.
The first is the difficulty diagnosing the infection and identifying the right antimicrobial to use, highlighted by a 2017 study: Bacterial Isolates from Canine External Ocular Disease and their Antimicrobial Sensitivities 2.
The second is whether the owner is able or willing to administer a topical treatment.
Here the evidence suggests that even when treatment is possible, people do not comply with clinical advice anything like as much as they claim.
Photon Therapeutics points to what it says is the nearest study there is, in which carers of young children with uveitis did not give the correct treatment in 75% of cases3.
If the device is as effective as claimed, then both these issues simply evaporate.
PhotonUVC costs £4,995.
https://photon-therapeutics.com
VetSurgeon.org product briefing: https://www.vetsurgeon.org/m/veterinary-product-briefing/138134
References
The update includes a new scoring system of low, moderate or high cancer risk which replaces the original numerical HDI scores and simplifies interpretation for clinicians, making the screening process easier to communicate with pet owners.
HT Vista says the device can now categorise cancer risk levels, based on malignant probability, with a sensitivity of 90% and a negative predictive value (NPV) of 98%.
The company says this translates to a “low cancer risk” result having a malignant probability of 10% or less, allowing veterinary teams to rule out cancer of lumps and bumps without the need for invasive procedures.
The tool can also now provide alerts for some of the low-risk cases, identifying them as lipomas, sebaceus adenomas or benign epithelial masses.
Liron Levy-Hirsch DVM MRCVS, Managing Director at HT Vista, said: "I am incredibly excited to enhance our already powerful HT Vista screening tool with a new diagnostic capability, providing veterinary teams with an even more comprehensive decision-support system.
"Our screening technology has already been a game-changer in early detection, and now, with the ability to flag specific tumour types, we are taking another significant step forward.
"This advancement empowers veterinary professionals to make even more informed decisions, supports shared decision-making with pet owners, and ultimately improves patient outcomes.
"By reducing the time from suspicion to diagnosis and treatment, we can detect cancer earlier, avoid the ‘wait and see’ approach, and help save more lives."
On the other end of the scale, a “high cancer risk” result has a malignant probability of 50% or more and indicates a stronger likelihood of malignancy.
HT Vista says these cases require additional diagnostic tests for mass identification.
The company highlights a big distinction between this and other screening modalities is that it can be nurse-led.
HT Vista will be on display and there will be live demonstrations at BSAVA Congress from the 20th to the 22nd of March 2025.
https://bit.ly/ht-vista-screening-tool
Ms Bowler faced four sets of charges, each of which contained sub-charges, summarised as follows:
Despite being served with the Notice of Inquiry, Ms Bowler decided not to attend the hearing due to ill-health but was represented by a counsel and solicitors.
The Committee did not find that Ms Bowler was medically unfit to attend on the basis of the medical evidence before it.
The Committee also concluded that it was in the public interest and interests of Ms Bowler to proceed with the hearing in her absence so that it could be concluded in a timely manner.
Ms Bowler’s counsel applied for parts of the hearing to be heard in private on health grounds, which was approved by the Committee.
It was also determined that any parts in the Committee’s decision or hearing that referred to Ms Bowler’s health would be redacted.
At the outset of the hearing, Ms Bowler’s counsel made admissions to five of the sub-charges which the Committee therefore found proven.
She also made some partial admissions in relations to a further 11 sub-charges.
After hearing a wide range of evidence, both written and oral, from Ms Bowler, the College, from clients and from an expert witness, the Committee found all charges proved except for four sub-charges.
On deciding whether the proved charges amounted to serious professional misconduct, the Committee took the following aggravating factors into account.
In mitigation:
In all, the Committee decided that the seriousness of the misconduct meant that a sanction was necessary to meet the public interest.
When deciding on whether to issue a reprimand with or without a warning, the Committee once again decided that the misconduct was too serious to allow for this.
It also decided that a reprimand and/or warning was not sufficient to protect animals and the wider public interest.
It then went onto consider whether a sanction of ‘suspension’ was sufficient but noted that it did not have enough evidence to show that Ms Bowler had shown significant insight to continue to practise unrestricted in the future.
The Committee eventually concluded that Ms Bowler’s conduct was incompatible with remaining on the Register.
Neil Slater, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee decided that the broad range of Ms Bowler’s misconduct which had spanned three years and eight months and involving injury or risk of injury to 18 animals, was incompatible with remaining on the Register and the public interest required removal from the Register even when all of Ms Bowler’s mitigation was taken into account.
“The Committee decided that it did not have sufficient evidence overall on Ms Bowler’s insight, current competence and future risk to persuade it that the lesser sanction of suspension was appropriate in this case.
“Although Ms Bowler had shown some insight, the Committee decided that she would need to have provided detailed evidence about her current practice before it could decide that she no longer represented a risk to animals in the future.
“The Committee therefore concluded that ‘removal from the Register’ was the appropriate and proportionate sanction because there had been a serious departure from professional standards, a reckless disregard for professional standards, multiple cases involving harm or risk of harm to animals and because, in Ms Bowler’s absence, it had been difficult to unravel whether she had an attitudinal problem.
“These were all factors in the Disciplinary Committee Sanctions Guidance that indicated that a sanction of removal was the appropriate sanction and, in the Committee’s decision, removal from the Register was the only sanction which would meet the public interest.
"It concluded that a lesser sanction would undermine public confidence in the profession and in the regulatory process.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
The courses are designed for self-paced learning and include practical hints and tips for treating common animal health issues in companion animals and livestock.
Small animal topics include cardiology, hypertension, dermatology, behaviour and gastroenterology.
Cattle topics include Q fever, reproduction and mobility.
In swine health, content focuses on respiratory health, neonatal disease and zoonotic conditions.
The Ceva Academy also includes downloadable resources, including practice posters, social media content and owner leaflets.
Dan Cripwell, vet channel marketing and technical manager at Ceva, said: “We have consolidated our portfolio of online learning courses and resources into one multi-species portal to give animal health professionals flexible access to high quality CPD and information in one convenient location.”
https://ceva.vbms-training.co.uk/dashboard
The report was put together by Hill’s new Cat Advisory Team (C.A.T.), a group of leaders from across the feline veterinary world, including private practice, academia and industry.
The report looks at cat demographics, population statistics, most common medical conditions, pet food advances, and the effect of cost on veterinary care and nutrition.
It also considers the fact that apparently, 60% of cats don't receive annual veterinary care, often due to clinic visit stress, noting that practices designated as 'Cat Friendly' report improved client satisfaction and an 81% increase in revenue.
It's a really interesting report, only slightly let down by the way it refers to cat owners by that awful finger-down-the-throat term: 'pet parents'.
https://na.hillsvna.com/en_US/resources-2/view/244
Elle says she created the course she wished she had when she first qualified, one which offers provides practical tools and tailored support to build confidence, overcome self-doubt, and thrive in veterinary practice.
She said: “I remember what it felt like to step into practice as a newly qualified vet nurse—feeling unsure, overwhelmed, and constantly questioning whether I was good enough.
"That’s why I created this course - to give vet professionals the support and confidence they deserve.”
The Confidence Coaching CPD Course includes:
Elle says the course is ideal for both vets and vet nurses, in particular those struggling with confidence in their clinical skills, and professionals looking to progress in their careers.
The course costs £350, but as part of the launch, Elle is offering a 25% limited-time discount for those who sign up early using the code: PVN25.
https://thepositivevetnurse.com/cpd-course
VetSurgeon.org has seen copies of correspondence from IVC which claims that its Pet Health Club has built up goodwill amongst the group's customers, and that the use of the term by other practices risks confusing the public and taking unfair advantage of the reputation built up by IVC.
One wonders which bright spark at IVC thought this was a good idea.
Bullying small independent businesses is not a great look, particularly in a caring profession such as this.
Besides which, where is the evidence that other practices using the term 'Pet Health Club' has any impact on IVC's business whatsoever?
After all, pet health plans, or clubs, are inexorably linked to the practice providing the subscription services they offer.
Nobody goes online looking for which practice offers the best pet health club, like they were choosing between the Hurlingham and the Groucho. It's something offered to the existing clients of a practice.
So there is literally zero chance of confusion over who is providing the service.
And on what planet does IVC think a client of another practice might be presented with an option to join a pet health club and think: "Oh this is that wonderfully smashy nicey club I have seen elsewhere. I must join it."
Ironically, given the CMA investigation, IVC's Pet Health Club website is opaque about which practice group (or practice) provides its own service.
How it is therefore possible to argue that it has built up a reputation is also unclear.
Finally, if you Google "Pet Health Club", you'll see that IVC already dominates the search results in a way that makes it vanishingly unlikely that its service is going to be confused with anyone else's.
This would all be laughable, except it's not if you're one of the 20 or 30 practices that VetSurgeon.org hears have been on the receiving end of a threatening letter.
Natalie Morris-Webb MRCVS from Malthouse Veterinary Group, one of the affected practices, said: “I was stunned to receive a letter from IVC claiming that our Pet Health Club, which we launched in 2017, is an infringement under the Trade Marks Act 1994 and that we’re using a registered word mark without the consent of the proprietor.
“It’s a ubiquitous term that lots of practices use and it quickly became apparent that these letters have been sent out far and wide.
"There are practices that have been using the term for well over 10 years and to rebrand will be very expensive and time-consuming for what are mostly small businesses.
“We’ve had some conversation with IVC’s representatives to discuss how else we can resolve the situation and whether such a heavy-handed approach is really necessary, because surely IVC don’t want a legal spat with so many independent businesses.
“It’s also very worrying to receive aggressive legal threats from a huge organisation, so it was reassuring to hear from other practices that are facing the same dilemma, and we want to extend our support to others in the same position.
"We’ve therefore launched We Are Spartacus where any practices that are affected can register their details.
"We can then work together and decide how to move forward as a collective."
Hopefully, there will be no need.
Hopefully, someone higher up the chain at IVC will stop this madness, admit that it called this one wrong and immediately write to the businesses it has already contacted, apologise profusely and withdraw its threat.
But if the company persists and wins it'll probably be a pyrrhic victory.
After all, pet health plans have largely been sold on the back of routine flea, worm and tick control, the need for which is starting to be questioned by the profession, particularly in the light of research pointing to the possible harm to other species, but also because of the greater focus on the cost of veterinary care.
The modules are 20 minutes long each.
The first: "The Key Components of Successful Anaesthesia", covers the basics of companion animal anaesthesia and analgesia.
The second module: "The Benefits of Zoletil", looks at Zoletil as an anaesthetic and explains the advantages it offers.
Licensed for cats and dogs, Zoletil comprises a coactive balance between Tiletamine & Zolazepam.
Virbac says it is ideal for short and medium duration anaesthesia with multiple administration routes including IV or IM administration, making it a versatile choice of anaesthetic.
https://vet-uk.virbac.com/home/products/dogs/anaesthetics--analgesics/zoletil-100.html
The sessions are:
https://www.bsavacongress.com/programme
Mrs Cole pleaded guilty to fraud in July 2024 at Crawley Magistrates’ Court and was sentenced to eight months in prison suspended for 12 months, 20 days rehabilitation activity and a £187 victim surcharge.
The College opened its own disciplinary investigation against Mrs Cole after receiving the certificate of conviction, which related to more than £13,000 of pet insurance fraud.
It then proceeded with the hearing in Mrs Cole’s absence as she had not responded to any of the communications sent to her by the College on the matter.
Having found the charge against her proven by the certificate of conviction, the Committee then determined that the conviction amounted to serious professional misconduct.
Dr Kathryn Peaty MRCVS, chairing the committee and speaking on its behalf, said: “The respondent’s conduct… was plainly dishonest and contravened a fundamental tenet of the profession.
"She abused her professional position in order to commit the offence.
"The dishonest conduct in this case related directly to the respondent’s professional life, as she was working as a veterinary nurse when she completed and submitted the fraudulent claims.
“Her conduct also constituted a breach of the trust owed to her employer and to the insurance company to which her dishonest claims were submitted.
"She put her professional colleagues at risk as their names were used on the clinical records which purportedly supported her dishonest claims.
“Her misconduct was repeated and sustained over a period of many years.
"Her modus operandi was sophisticated and premeditated.
“The respondent’s conduct clearly had the potential to bring the profession into disrepute and to undermine public trust in the profession.
"A member of the public would be rightly appalled to learn that a veterinary nurse had abused her position by submitting false claims in this way.”
The Committee found that there were no mitigating factors, and that aggravating factors included the premeditated nature of Mrs Cole’s fraud, the clear breaches of trust in respect of her colleagues, her clients and the insurance companies, the significant financial gain made from her fraud and the fact that the fraudulent activities were sustained and repeated over a period of four and a half years.
Kathryn added: “Taking into account the gravity of her misconduct, the need to maintain standards of probity in the profession, especially in relation to practice records and the submission of insurance claim documents, as well as the maintenance of public confidence in the profession, the Committee has resolved to direct the Registrar to remove the respondent’s name from the Register.
www.rcvs.org.uk/disciplinary
The panel will present the latest information on the prevalence of this zoonotic disease, review prevention strategies, and highlight the significance of cystic echinococcosis in humans.
The panelists are:
Dr Carolyn Kyte MRCVS (pictured), Elanco's UK Technical Consultant said: “We are concerned about potential changes in the distribution of Echinococcus granulosus in the UK and a subsequent change in zoonotic risk.
"We are hoping this cross-disciplinary discussion will provide Congress and Expo attendees with the latest insights the profession needs to allow individual, risk-based parasite control in dogs.
"The responsible use of parasiticides needs a true One-Health collaborative approach.”
The grants are available for small-scale clinical research projects in areas of the affiliate speciality, focusing on diseases affecting companion animals.
The projects will be selected in the hope that the study results will have a rapid and positive impact on the way diseases are diagnosed, managed and treated in general practice, as well as at a specialist level.
BSAVA says applications are particularly welcome from practitioners, as well as academics or joint applications between practice and academia.
Chris Scudder, from the Small Animal Medicine Society said: “We are delighted to be able to collaborate with BSAVA PetSavers in supporting innovative research in small animal internal medicine.
"We have a shared goal of advancing the health and well-being of small animals.
"Their invaluable and generous support enables us to fund research that makes a meaningful difference for cats, dogs, and their owners.”
Applications are also open for the BSAVA PetSavers Clinical Research Project grant, where funding of up to £20,000 is available.
https://bsava.com/petsavers/apply-for-funding/clinical-research-projects/.
The company has prepared practice marketing materials to support the campaign to educate pet owners on the signs of anxiety in cats and dogs, which are available from its Account Managers.
The campaign is being fronted by TV personality and radio presenter, Kate Lawler (pictured), who has taken on the role of official ambassador having experienced anxiety in her rescue Terrier cross, Shirley.
Ceva has partnered with Battersea Dogs and Cats Home for the campaign and will be making a donation of £1 for every Adaptil product sold during March.
http://www.petanxiety.co.uk
Reasonable adjustments can include changing working arrangements and providing equipment, services and support.
The campaign will address common myths and misconceptions surrounding reasonable adjustments and highlight the legal obligations of leaders and managers around implementation.
The campaign, which will run until the end of July, is being launched after an RCVS/British Veterinary Chronic Illness Support (BCVIS) survey concluded there is a need to increase awareness about reasonable adjustments, promote wider discussion and equip organisations with the information they need to implement them.
The research also indicated that improved knowledge of legislation is needed, with communication also being raised as an important issue, so that individuals feel empowered to ask for the support they need.
MMI Lead, Rapinder Newton, said: “Our ‘Let’s talk adjustments’ campaign will support people to have these important conversations by sharing information, educational resources and guidance on good practice.
"It will also provide examples of different types of adjustments, including examples that are specific to the veterinary context.
“We know that physical and mental health are deeply interconnected.
"Reasonable adjustments can support both physical and mental health but also helps to safeguard mental health through allowing individuals with disabilities to thrive.
“We will be keeping people updated on the campaign, which has its own dedicated section on the RCVS website, via the RCVS social media channels, as well as providing information in RCVS newsletters, so do keep an eye out for this over the coming months.”
https://www.rcvs.org.uk/lifelong-learning/leadership-diversity-and-inclusion/reasonable-adjustments-campaign/
Photo courtesy: https://depositphotos.com
Jane, who has also just been appointed to chair IVC's Small Animal Clinical Board, was awarded the certification in recognition of her dedication to professional development, having achieved 180 post graduate points for the Masters level award.
Jane already holds a PG certificate in Emergency Medicine and Surgery, a postgraduate diploma in Advanced Veterinary Practice Sciences, GP certificates in Small Animal Surgery and Advanced Small Animal Orthopaedic Surgery and a Focus Certificate in Veterinary Arthroscopy.
She is also an RCVS advanced practitioner in small animal surgery and in emergency medicine and critical care and is currently studying for further certifications in pain management and small animal musculoskeletal ultrasound.
Jane said: "I have always loved learning, and CPD has been incredibly important throughout my career to date.
"I’ve worked hard over the last 35 years to gain additional qualifications and to take advantage of every development opportunity I could to build on my own knowledge and capabilities.
“I very much look forward to sharing this experience and working with the rest of the board to support our small animal colleagues across IVC Evidensia in providing the best possible standards of care.”
The 4% increase was approved by the Privy Council and the Department for Environment, Food & Rural Affairs.
Dr Tshidi Gardiner, RCVS Treasurer, said: “As with last year, RCVS Council recognises that we are living in difficult economic times, and have tried to keep the fee increase to a minimum.
"However, it is important that we increase fees in line with inflation, as well as take into account additional related costs, to ensure we are fulfilling our regulatory remit to the best of our abilities and meet our strategic priorities.”
Veterinary surgeons need to pay their annual renewal by 1st April and will be sent their fee notices within the first two weeks of March.
Anyone who has not paid their fee by 1st May will incur a higher fee charge of £36, with non-payment by 1st June risking removal from the Register and ineligibility to practise.
As part of the annual renewal process, all individual vets will also need to log into their online MyAccount to confirm their registration and contact details and declare any convictions.
Anyone who expects to encounter any difficulties in paying their fees should contact the RCVS Finance Team on finance@rcvs.org.uk or 020 7202 0722.
The VMD's ruling sets a chilling precedent for the curtailment of free speech by a Government body.
The ruling came to light after VetSurgeon.org published an independent video news report relating to the launch of Bravecto Injectable, a new yearly flea treatment for dogs.
The film was neither paid for nor commissioned by the manufacturer, and nor did the maker exercise editorial control over its content.
The film was clearly labelled for and aimed at veterinary professionals, and its intent was not to promote the sale or supply of a prescription medicine, but rather to inform vets and nurses about the new product, albeit in an enthusiastic manner.
It was therefore not an advertisement, but journalism.
The Dictatorship nevertheless argued that it defines any social media content that mentions the brand name of a prescription veterinary medicine and which does not give a balanced overview of all the other treatment options for a given condition, as an advertisement.
This, it said, is regardless of whether content is created by the manufacturer or supplier of drug to promote sales of their product, or any member of the public or journalist who just wants to talk about or report on a prescription medicine publicly without any intent to promote sales.
The Dictatorship's position is that any such content can only appear in spaces dedicated to the appropriate audiences.
Notwithstanding the fact that all of VetSurgeon.org's social media channels are dedicated to the appropriate audiences, it leaves us in the almost laughable position where, according to the VMD, the BBC is allowed to report about powerful prescription medicines for humans in a way that inevitably promotes their supply, but VetSurgeon.org cannot report the launch of ... wait for it ... a flea treatment.
However the VMD then shared its incontinent interpretation of the law in a series of emails in which it was unable to provide a consistent definition of where it would allow content about prescription veterinary medicines to be published.
It first claimed (without any supporting evidence of any law to this effect), that:
"... it would need to be on a closed page which only followers could view would require active confirmation of the follower’s professional status before allowing access."
However, it swiftly backtracked, presumably realising that this definition would require Vet Times to remove most of its content from public view, including actual advertisements for veterinary prescription medicines published by the manufacturer.
When pressed, the VMD changed tack to a rather looser definition:
"Regulation 11(3) of the VMR does allow you to advertise POM-V products at vets and vet nurses, however to ensure this wouldn’t also be considered as advertising to the general public, it would need to be in a closed space, separate from the general public and directed at veterinary healthcare professionals. For example, on a website, or closed social media group."
However, it then presumably realised that Vet Times would still have to remove most of its content because it is not a closed space, and loosened its definition further still.
"Please note that, where an advertisement for POM-V or POM-VPS veterinary medicine appears in a space dedicated to the appropriate audiences this would not be a breach of Regulation 11(1)(a) due to Regulation 11(3) and Regulation 11(5)."
Clearly the Dictatorship was making it up as it went along.
Nevertheless, it threatened VetSurgeon.org that it would contact TikTok and demand removal of the film.
So what does this matter?
Two reasons.
Firstly, it may just be a report about a flea treatment, but there is an important principle at stake here: it is simply not acceptable for the Government to censor free speech about medicines by journalists or members of the public.
This, you would think, is so blatantly obvious that it calls into question the overall competence of the Veterinary Medicines Directorate.
Secondly, the ruling also demonstrates the VMD's backward-looking, Canute-like view of the world we now live in.
People talk and social media is awash with information about prescription veterinary medicines; just try typing 'Bravecto Injectable' into TikTok.
As we all know much of what you find online is false.
Fighting misinformation online is an unwinnable fight.
So perhaps instead, the VMD should promote the dissemination of accurate information in order to counter the misinformation.
Bear in mind, it is only the VMD's interpretation of the law which dictates that a manufacturer cannot publish information which mentions a brand name or give a balanced overview of all treatment options because it would promote the supply or prescription of a veterinary medicine.
It could equally well be argued that manufacturers publishing strictly factual information, ie devoid of hyperbole, would NOT be intended to promote the supply or prescription, but instead to counter false information and provide owners with information which time-poor vets are not always able to.
That would be a more pragmatic approach which would do far more good than trying to censor independent journalists and the public.